The longstanding ms lesion

Brain

Volumn 114, Issue 3, 1991, Pages 1271-1280

  Barnes, D ^a   Munro, P M G ^a   Youl, B D ^a   Prineas, J W ^a   Mcdonald, W I ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; CLINICAL ARTICLE; EXTRACELLULAR SPACE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; RELAXATION TIME; TISSUE INJURY; TRANSMISSION ELECTRON MICROSCOPY; WHITE MATTER;

ADULT; BRAIN; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HUMAN; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON; MULTIPLE SCLEROSIS; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; SUPPORT, NON-U.S. GOV'T;

EID: 0025850757     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/114.3.1271     Document Type: Article

References (25)

1. Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN (1987) Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. Journal of Neurology, Neurosurgery and Psychiatry, 50, 125-133
2. Barnes D, McDonald WI, Landon DN, Johnson G (1988) The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain, 111, 83-94
3. Braunschweiger PG, Schiffer LM, Furmanski P (1986) 'H-NMR relaxation times and water compartmentalization in experimental tumor models. Magnetic Resonance Imaging, 4, 335-342
4. Broman T (1964) Blood-brain barrier damage in multiple sclerosis: supravital test-observations. Acta Neurologica Scandinavica, 40, Supplement 10, 21-24
5. Castro ME, Treiber EO, Lunt JA, Boisvert DPJ, Allen PS (1987) Comparison of in-vivo and in-vitro R2 of protons in cats with experimental brain edema. Sixth Annual Society of Magnetic Resonance in Medicine Meeting, Abstract 715
6. Gonzalez-Scarano F, Grossman RI, Galetta, S, Atlas SW, Silberberg DH (1987) Mutiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Annals of Neurology, 21, 300-306
7. Gounot D, Armspach JP, Rumbach L, Chambron J (1989) Quantitative analysis of multiple sclerosis in clinical MRI. Eighth Annual Society of Magnetic Resonance in Medicine Meeting, Abstract 726
8. Hawkins CP, Munro PMG, Mackenzie F, Kesselring J, Tofts PS, du Boulay EPGH etal. (1990) Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain, 113, 365-378
9. Kermode AG, Tofts PS, Thompson AJ, MacManus DG, Rudge P, Kendall BE et al. (1990) Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology, Cleveland, 40, 229-235
10. Koopmans RA, Li DKB, Oger JJF, Mayo J, Paty DW (1989) The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology, Cleveland, 39, 959-963
11. Larsson E-M, Holtas S, Nilsson O (1989) Gd-DTPA-enhanced MR of suspected spinal multiple sclerosis. American Journal of Neuroradiology, 10, 1071-1076
12. Larsson HBW, Frederiksen J, KJaer L, Henriksen O, Olesen J (1988) In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magnetic Resonance in Medicine, 7, 43-55
13. Miller DH, Rudge P, Johnson G, Kendall BE, MacManus DG, Moseley IF et al. (1988) Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain, 111, 927-939
14. Morgan BP, Campbell AK, Compston DAS (1984) Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis. Lancet, 2, 251-255
15. Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Yoshizaki K (1982) Proton nuclear magnetic resonance studies on brain edema. Journal of Neurosurgery, 56, 747-752
16. Parrtsh RG, Kurland RJ, Janese WW, Bakay L (1974) Proton relaxation rates of water in brain and brain tumors. Science, 183, 438-439
17. PÉRIER O, Grégoire A (1965) Electron microscopic features of multiple sclerosis lesions. Brain, 88, 937-952
18. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology, 13, 227-231
19. Prineas J (1975) Pathology of the early lesion in multiple sclerosis. Human Pathology, 6, 531-554
20. Prineas JW, Connell F (1978) The fine structure of chronically active multiple sclerosis plaques. Neurology, New York, 28, Supplement, 68-75
21. Rumbach L, Sellal F, Chambron J, Wärter JM, Collard M (1988) MRI and T2 relaxation time measurement in multiple sclerosis brain lesions. Journal of Neurology, 235, Supplement 591-592
22. Scolding NJ, Morgan BP, Houston A, Campbell AK, Linington C, Compston DAS (1989) Normal rat serum cytotoxicity against syngeneic oligodendrocytes: complement activation and attack in the absence of anti-myelin antibodies. Journal of the Neurological Sciences, 89, 289-300
23. Thompson AJ, Kermode AG, MacManus DG, Kingsley DPE, Kendall BE, Moseley IF etal. (1989) Pathogenesis of progressive multiple sclerosis. Lancet, 1, 1322-1323
24. Walker RWH, Thompson EJ, McDonald WI (1985) Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features. Journal of Neurology, 232, 250-259
25. Weller RO (1985) Pathology of multiple sclerosis. In: McAlpine’s Multiple Sclerosis. Edited by W. B. Matthews, E. D. Acheson, J. R. Batchelor and R. O. Weller. Edinburgh: Churchill Livingstone, pp. 301-343